• Text Resize A A A
  • Print Print
  • Share Share on facebook Share on twitter Share

Hepatitis Tags: Viral Hepatitis Action Plan

Hidden Casualties
IDSA, HIVMA, & PIDS identify infectious disease consequences of the opioid crisis, urge coordinated and sustained action.
Hepatitis C
The HCV program, led by officers from the Commissioned Corps, is a model of collaborative practice between medical providers, pharmacists, laboratory services and case managers in the Great Plains Area.
Hepatitis C
HIV/HCV Coinfection Awareness Day established May 17, 2018 highlights new curative HCV treatments for people living with HIV.
National Viral Hepatitis Action Plan
Key accomplishments by federal partners featured in 2015 progress report from the HHS Office of HIV/AIDS and Infectious Disease Policy.
Win the Fight Against Viral Hepatitis
HHS’s Corinna Dan describes advances and opportunities to combat the hepatitis B and hepatitis C epidemics in the United States.
Special Topic
Lucinda Porter, a nurse who writes for the HCV Advocate and HepMag.com, explores stigma about hepatitis and drug use and shares recommendations for addressing it.
Hidden Casualties
At NASTAD’s 2017 viral hepatitis technical assistance meeting, public health staff shared how they are responding to the hidden casualties of the opioid epidemic.
Hepatitis B
New hepatitis B resource supports providers in hepatitis B testing, vaccination, and linkage to care, highlights key actions to increase hepatitis B services.
Win the fight against viral hepatitis
HHS’s Corinna Dan discusses how she frames the growing problem of viral hepatitis in the U.S. and why we are losing ground in the fight to combat it.
Viral Hepatitis
New Report: ITFDE convened to review the epidemiology of hepatitis B and hepatitis C, the effectiveness of prevention interventions, and additional elimination goals.

Pages

  • of 15
  • >